California is the first state in the country to partner with a nonprofit to develop, produce and sell its own insulin.

California will cap insulin co-pays at $35 and launch CalRx state-branded insulin in 2026 under new legislation signed by ...

The International Diabetes Federation officially recognized a fifth form of the disease this year, a landmark step that comes ...

As of January, California is the first state in the country to partner with a nonprofit to develop, produce and sell its own ...

In a recent study published in Nature, researchers report the design and experimental efficacies of NNC2215, a novel insulin conjugate comprising synthetically added glucose-binding macrocycles and ...

Zimislecel is an allogeneic stem cell-derived islet cell therapy that could eliminate the need for insulin in those who have ...

Calcium (Ca2+) drives many cellular functions, though the way it controls quality of proteins in the endoplasmic reticulum ...

Imagine your body as a complex orchestra with insulin as the conductor that keeps every section in harmony. In diabetes, it ...

Drugmaker Cipla has launched Afrezza (insulin human) inhalation powder, the company said, about a year after the product got ...

Mounjaro is a new medication used to manage blood sugar levels in people who have type 2 diabetes. This medication offers weight loss and cardiovascular benefits, which can also help with insulin ...

California’s new CalRx program will offer state-made, low-cost insulin, giving Kern County residents easier access to an ...